TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT06178991 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06523556 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05096585 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT06607302 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT05130788 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT04766944 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study NCT06353581 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05422105 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06191497 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT05541458 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05027594 — Predictive Biomarker (PRD): EIF2AK3 mRNA
Genes: EIF2AK3; PEK; PERK
Study NCT05805631 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05805631 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06063785 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05177926 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04715620 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT05018533 — Predictive Biomarker (PRD): MEX3B mRNA
Genes: MEX3B; KIAA2009; RKHD3; RNF195
Study NCT06445543 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05334745 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06409520 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT05052632 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT06285435 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT05808686 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05062174 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT05740735 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study NCT04513184 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04965155 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05094622 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05573477 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05752760 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06626412 — Predictive Biomarker (PRD): SV2A mRNA
Genes: SV2A; KIAA0736; PSEC0174
Study NCT06626412 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT05979454 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study NCT05457790 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05764928 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05764928 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05764928 — Safety Biomarker (SAF): Interleukin 12
Study NCT05952349 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05952349 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT06241742 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03311542 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03311542 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT03311542 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06324565 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT06324565 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04657861 — Predictive Biomarker (PRD): TNFSF13 mRNA
Genes: TNFSF13; APRIL; TALL2; ZTNF2; UNQ383/PRO715
Study NCT04657861 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05842447 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06375707 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06375707 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04753606 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT05419453 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT05419453 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05419453 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05419453 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06731907 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT06731907 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05657483 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT05150496 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06610110 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT04988295 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04988295 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05062980 — Predictive Biomarker (PRD): TUSC2 mRNA
Genes: TUSC2; C3orf11; FUS1; LGCC; PDAP2
Study NCT05879341 — Predictive Biomarker (PRD): FNDC5 mRNA
Genes: FNDC5; FRCP2
Study NCT05879341 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05938829 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study NCT03728829 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05423626 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT05049954 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05156892 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT05368376 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05357573 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT05034146 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT06066034 — Predictive Biomarker (PRD): Leucine-rich alpha-2-glycoprotein
Genes: LRG1; LRG
Study NCT06066034 — Predictive Biomarker (PRD): SREBF1 mRNA
Genes: SREBF1; BHLHD1; SREBP1
Study NCT00272493 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06035679 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06262685 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04673318 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06215430 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT06215430 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT06215430 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT04984733 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT05402748 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05402748 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06249347 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study NCT06634030 — Pharmacodynamic Biomarker (PDY): Platelet-derived growth factor B
Genes: PDGFB; PDGF2; SIS
Study NCT06723990 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06528301 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05692297 — Surrogate Endpoint (SUR): Serum calcium
Study NCT05692297 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04885452 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00100581 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04764669 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study NCT05202548 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCR2 mRNA
Genes: CCR2; CMKBR2
Study NCT05202548 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study NCT05202548 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05202548 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT05202548 — Predictive Biomarker (PRD): SOCS3 mRNA
Genes: SOCS3; CIS3; SSI3
Study NCT05166980 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05405920 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05830708 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05830708 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04647916 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05402397 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT06662864 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06668402 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06001086 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00040586 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06163963 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study NCT05438368 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study NCT06513351 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT04987879 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT05773989 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT05826483 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05190094 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05190094 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04701957 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05695937 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT05695937 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00018304 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05544240 — Predictive Biomarker (PRD): SYNC mRNA
Genes: SYNC; SYNC1
Study NCT05384626 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05901194 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT04806672 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT04806672 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT05419765 — Predictive Biomarker (PRD): PNPLA3 mRNA
Genes: PNPLA3; ADPN; C22orf20
Study NCT05419765 — Predictive Biomarker (PRD): TM6SF2 mRNA
Genes: TM6SF2
Study NCT05419765 — Predictive Biomarker (PRD): HSD17B13 mRNA
Genes: HSD17B13; SCDR9; SDR16C3; HMFN0376; UNQ497/PRO1014
Study NCT05419765 — Predictive Biomarker (PRD): LIPA mRNA
Genes: LIPA
Study NCT04936334 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06667973 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT04805502 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04805502 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05050916 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06159621 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT06621758 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06475443 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06667934 — Predictive Biomarker (PRD): STAT1 mRNA
Genes: STAT1
Study NCT06682819 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT06682767 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT04708782 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06494410 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT06205342 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05666453 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT06561048 — Predictive Biomarker (PRD): ITK mRNA
Genes: ITK; EMT; LYK
Study NCT06367166 — Predictive Biomarker (PRD): FN1 mRNA
Genes: FN1; FN
Study NCT06367166 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT05918068 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04869943 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT04869943 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04507126 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05017415 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT06705504 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06705504 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06705504 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06705504 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06705504 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06533033 — Predictive Biomarker (PRD): ZNF582 mRNA
Genes: ZNF582
Study NCT04965142 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05001516 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT06327932 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study NCT05782426 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05782426 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06305156 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06042010 — Safety Biomarker (SAF): MMP-1
Genes: MMP1
Study NCT05428423 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06301958 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05455138 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT04762485 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT05243524 — Predictive Biomarker (PRD): MVP mRNA
Genes: MVP; LRP
Study NCT05854433 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05854433 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT05490394 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT04672941 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT04902833 — Predictive Biomarker (PRD): PKLR mRNA
Genes: PKLR; PK1; PKL
Study NCT04759664 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05768061 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04926220 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05526066 — Safety Biomarker (SAF): Ornithine transcarbamylase
Genes: OTC
Study NCT04869618 — Predictive Biomarker (PRD): HGD mRNA
Genes: HGD; HGO
Study NCT06147843 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT05955612 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT06458205 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06130579 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05686239 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06650423 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06650423 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06650423 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06650423 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06580873 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04984031 — Predictive Biomarker (PRD): AIFM1 mRNA
Genes: AIFM1; AIF; PDCD8
Study NCT04984031 — Predictive Biomarker (PRD): CASP9
Genes: MCH6; ICE-LAP6; APAF-3; PPP1R56
Study NCT05620420 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT04795882 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04795882 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04337580 — Predictive Biomarker (PRD): FASN mRNA
Genes: FASN; FAS
Study NCT05531786 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT05531786 — Predictive Biomarker (PRD): IRAK1 mRNA
Genes: IRAK1; IRAK
Study NCT05531786 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study NCT04645147 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05822167 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT05776173 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06327503 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT06327503 — Predictive Biomarker (PRD): GDNF mRNA
Genes: GDNF
Study NCT06327503 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06327503 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06327503 — Safety Biomarker (SAF): BDNF
Study NCT06327503 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06327503 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05482373 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06485440 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05538780 — Predictive Biomarker (PRD): TTN mRNA
Genes: TTN
Study NCT05574673 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT05104853 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study NCT04827745 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04915768 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05207423 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05207423 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06231693 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04733287 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT04774419 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT06308510 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05131594 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04928820 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04903210 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05265923 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06366347 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT06366347 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05133271 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06105632 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06105632 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06105632 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06105632 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06301126 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05312593 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05312593 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT05672251 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05683093 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05299931 — Predictive Biomarker (PRD): UST mRNA
Genes: UST; DS2ST
Study NCT05397730 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06216808 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04985877 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04985877 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05772728 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05772728 — Predictive Biomarker (PRD): BCL6 mRNA
Genes: BCL6; BCL5; LAZ3; ZBTB27; ZNF51
Study NCT05772728 — Predictive Biomarker (PRD): CXCL13 mRNA
Genes: CXCL13; BCA1; BLC; SCYB13
Study NCT05772728 — Predictive Biomarker (PRD): ICOS mRNA
Genes: ICOS; AILIM
Study NCT05772728 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT05772728 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05772728 — Predictive Biomarker (PRD): DNMT3A mRNA
Genes: DNMT3A
Study NCT05772728 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT05772728 — Predictive Biomarker (PRD): TET2 mRNA
Genes: TET2; KIAA1546; Nbla00191
Study NCT06460233 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06023082 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT04921137 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04921137 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05232695 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study NCT05232695 — Predictive Biomarker (PRD): NRG4 mRNA
Genes: NRG4
Study NCT05831930 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04708756 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05467397 — Predictive Biomarker (PRD): TSC2
Genes: tuberin; LAM; PPP1R160
Study NCT06195371 — Predictive Biomarker (PRD): CASP3 mRNA
Genes: CASP3; CPP32
Study NCT05602831 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06488378 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT06488378 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study NCT05219162 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT06230705 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06320054 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05231226 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study NCT00001024 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00001024 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P